Ambient air pollution directly leads to poorer health outcomes, and even short-term exposure to fine particulate matter can increase a person’s risk of adverse cardiovascular events.
Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.
Numerous healthcare organizations have joined forces to launch a new ad campaign focused on helping black women learn more about monitoring and managing their blood pressure.
The guidelines were specifically designed so that they could apply to patients from any country or socioeconomic group.
Limiting saturated fat intake can decrease a person’s risk of adverse cardiovascular events by a significant margin, according to a new systematic review of 15 different studies.
The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.
Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.
The World Health Organization estimates that 82 million people will be affected by dementia by the year 2030—could maintaining a healthy heart be one way to keep such conditions at bay?
Drinking just one sugary drink per day can increase a woman’s risk of cardiovascular disease (CVD) by 19%, according to new findings published in the Journal of the American Heart Association.
Antihypertensive medications don’t increase a person’s risk of testing positive for COVID-19, according to new research published in the New England Journal of Medicine.
There’s a reason to feel quite optimistic about these numbers—the rise comes from an updated definition of hypertension, one first suggested by the American College of Cardiology and American Heart Association.
Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.